CDC25A Antikörper (N-Term)

Produktnummer ABIN3030441

Der Kaninchen Polyklonal anti-CDC25A Antikörper (ABIN3030441) detektiert spezifisch CDC25A in WB und ELISA. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für CDC25A Antikörper (N-Term) (ABIN3030441)

Target: CDC25A (Cell Division Cycle 25 Homolog A (S. Pombe) (CDC25A))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser CDC25A Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Produktdetails anti-CDC25A Antikörper

Bindungsspezifität: N-Term

Verwendungszweck: Cdc25A Antibody

Aufreinigung: Antigen affinity

Immunogen: This Cdc25A antibody was produced from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human Cdc25A.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Titration of the Cdc25A antibody may be required due to differences in protocols and secondary/substrate sensitivity.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the Cdc25A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Details zu CDC25A

Target: CDC25A (Cell Division Cycle 25 Homolog A (S. Pombe) (CDC25A))

Andere Bezeichnung: Cdc25A

Hintergrund: CDC25A is a member of the CDC25 family of phosphatases. CDC25A is required for progression from G1 to the S phase of the cell cycle. It activates the cyclin-dependent kinase CDC2 by removing two phosphate groups. CDC25A is specifically degraded in response to DNA damage, which prevents cells with chromosomal abnormalities from progressing through cell division. CDC25A is an oncogene, although its exact role in oncogenesis has not been demonstrated.

UniProt: P30304

Pathways: Zellzyklus, Mitotic G1-G1/S Phases, M Phase